Publications in collaboration with researchers from Hospital Clinico Universitario de Valencia (19)

2024

  1. Emerging Role of Extracellular Vesicles as Biomarkers in Neurodegenerative Diseases and Their Clinical and Therapeutic Potential in Central Nervous System Pathologies

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

  2. Extracellular Vesicles as Mediators of Neuroinflammation in Intercellular and Inter-Organ Crosstalk

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

2023

  1. Extracellular vesicles from mesenchymal stem cells reduce neuroinflammation in hippocampus and restore cognitive function in hyperammonemic rats

    Journal of Neuroinflammation, Vol. 20, Núm. 1

2022

  1. Hyperammonemia Alters the Function of AMPA and NMDA Receptors in Hippocampus: Extracellular cGMP Reverses Some of These Alterations

    Neurochemical Research, Vol. 47, Núm. 7, pp. 2016-2031

  2. Intracellular and extracelluar cyclic GMP in the brain and the hippocampus

    Vitamins and Hormones (Academic Press Inc.), pp. 247-288

  3. Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy

    International Journal of Molecular Sciences, Vol. 23, Núm. 20

2021

  1. Patients with minimal hepatic encephalopathy show altered thermal sensitivity and autonomic function

    Journal of Clinical Medicine, Vol. 10, Núm. 2, pp. 1-18

2019

  1. Chronic hyperammonemia alters extracellular glutamate, glutamine and GABA and membrane expression of their transporters in rat cerebellum. Modulation by extracellular cGMP

    Neuropharmacology, Vol. 161

  2. Differential role of interleukin-1β in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats

    FASEB Journal, Vol. 33, Núm. 9, pp. 9913-9928

  3. Extracellular cGMP Reverses Altered Membrane Expression of AMPA Receptors in Hippocampus of Hyperammonemic Rats: Underlying Mechanisms

    Molecular Neurobiology, Vol. 56, Núm. 6, pp. 4428-4439

  4. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications

    Acta Physiologica, Vol. 226, Núm. 2

  5. Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy

    Journal of Translational Medicine, Vol. 17, Núm. 1

  6. Tadalafil Treatment Improves Inflammation, Cognitive Function, And Mismatch Negativity Of Patients With Low Urinary Tract Symptoms And Erectile Dysfunction

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 160, pp. 88-93

2015

  1. Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy

    Neurochemistry International, Vol. 88, pp. 15-19

  2. Sildenafil reduces neuroinflammation and restores spatial learning in rats with hepatic encephalopathy: Underlying mechanisms

    Journal of Neuroinflammation, Vol. 12, Núm. 1

2014

  1. Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain

    NeuroMolecular Medicine, Vol. 16, Núm. 2, pp. 360-375

2007

  1. Determination of the prognostic value blood levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in advanced non-small cell lung cancer (NSCLC) patients

    EJC SUPPLEMENTS

  2. Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?

    EJC SUPPLEMENTS